PubRank

M A Tempero

Author PubWeight™ 24.86‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association. Gastroenterology 1999 2.34
2 Outpatient treatment with (131)I-anti-B1 antibody: radiation exposure to family members. J Nucl Med 2001 1.47
3 A white paper: the product of a pancreas cancer think tank. Cancer Res 2001 1.39
4 Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer. Br J Cancer 2005 1.34
5 A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer. Br J Cancer 2013 1.12
6 Correlative study on expression of CA 19-9 and DU-PAN-2 in tumor tissue and in serum of pancreatic cancer patients. Cancer Res 1988 0.97
7 A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer. Br J Cancer 2013 0.94
8 Comparative studies on the expression of tumor-associated glycoprotein (TAG-72), CA 19-9 and DU-PAN-2 in normal, benign and malignant pancreatic tissue. Int J Cancer 1988 0.92
9 Pancreatic cancer. Curr Opin Oncol 1998 0.89
10 Intracellular accumulation of unconjugated bilirubin inhibits phytohemagglutin-induced proliferation and interleukin-2 production of human lymphocytes. Dig Dis Sci 1996 0.89
11 Reactivity of CO17-1A and B72.3 in benign and malignant pancreatic diseases. Hum Pathol 1989 0.86
12 Correlative studies on antigenicity of pancreatic cancer and blood group types. Cancer Detect Prev Suppl 1987 0.85
13 Monoclonal antibody CO17-1A and leukapheresis in immunotherapy of pancreatic cancer. Hybridoma 1986 0.85
14 The effect of garlic extract on human metabolism of acetaminophen. Cancer Epidemiol Biomarkers Prev 1994 0.84
15 Unconjugated bilirubin inhibits in vitro major histocompatibility complex-unrestricted cytotoxicity of human lymphocytes. Biochim Biophys Acta 1996 0.81
16 The importance of luminal factors in neomucosal growth. J Surg Res 1986 0.81
17 The value of hepatic ultrasound and biochemical liver tests in screening for liver metastases. J Clin Oncol 1986 0.80
18 The undifferentiated malignant neoplasm. Identification of lymphoma arising in skeletal muscle by immunohistochemical analysis. JAMA 1985 0.80
19 Flow cytometric measurement of intracellular bilirubin in human peripheral blood mononuclear cells exposed to unconjugated bilirubin. Clin Biochem 1992 0.79
20 Fatal pulmonary toxicity resulting from treatment with gemcitabine. Cancer 1998 0.79
21 Diagnostic use of radiolabeled antibodies for cancer. Oncology (Williston Park) 1995 0.78
22 Modulation of tumor-associated antigen expression on human pancreatic and prostate carcinoma cells in vitro by alpha- and gamma-interferons. J Immunother Emphasis Tumor Immunol 1995 0.78
23 Disseminated Mycobacterium kansasii presenting with skin lesions in a patient with chronic lymphocytic leukemia. Med Pediatr Oncol 1981 0.78
24 Comparative studies on expression of CA 19-9 and DU-PAN-2 in pancreatic cancer tissue. Int J Pancreatol 1988 0.78
25 Patient-specific dosimetry of indium-111- and yttrium-90-labeled monoclonal antibody CC49. J Nucl Med 1997 0.76
26 Unconjugated bilirubin inhibits in vitro cytotoxic T lymphocyte activity of human lymphocytes. Biochim Biophys Acta 1996 0.75
27 Complications and technical limitations of hepatic arterial infusion catheter placement for chemotherapy. J Vasc Interv Radiol 1998 0.75
28 Hypersensitivity to therapeutic murine monoclonal antibodies. Nebr Med J 1994 0.75
29 In vitro regulation of human lymphocyte proliferation by selenium. Biol Trace Elem Res 1986 0.75
30 Radiolabeled iododeoxyuridine: safety evaluation. J Nucl Med 1996 0.75
31 Dose-related comparison of antibody-dependent cellular cytotoxicity with chimeric and native murine monoclonal antibody 17-1A. Improved cytolysis of pancreatic cancer cells with chimeric 17-1A. Int J Pancreatol 1994 0.75
32 Characterization of bilirubin transport system by human peripheral blood mononuclear cells. J Leukoc Biol 1992 0.75
33 Hexamethylmelamine and melphalan as salvage therapy in advanced ovarian carcinoma. J Surg Oncol 1982 0.75
34 Quantitation of metastatic tumor burden from human colon tumor xenografts using radiolabelled monoclonal antibody 17-A fragments. Tumour Biol 1992 0.75
35 Purification and analysis of glycoproteins bearing blood group-A determinants from hamster pancreatic ductal adenocarcinomas. Carcinogenesis 1992 0.75
36 Thrombocytopenia and laboratory evidence of disseminated intravascular coagulation after shunts for ascites in malignant disease. Cancer 1985 0.75
37 Comparison of subcutaneous and intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor for peripheral blood stem cell mobilization. J Hematother 1995 0.75
38 Immunohistochemistry with monoclonal antibody B72.3 as an adjunct in the cytologic diagnosis of pancreatic carcinoma. Mod Pathol 1988 0.75
39 Detection of metastatic liver disease. Use of liver scans and biochemical liver tests. JAMA 1982 0.75